+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MEDPLUS

Medplus Health Services Share Price

₹704.95 -9.8 (-1.37%)
31.04% Fall from 52W High

31 Jul, 2026 3:54 PM (IST)

Medplus Health Services live price: ₹704.95. It opened at ₹724 vs previous close ₹715; intraday high/low: ₹724/₹699. The 50 & 200 DMA stand at ₹804.50/₹828.20.

Medplus Health Services Performance

  • Today's Low
  • ₹699
  • Today's High
  • ₹724
  • 52 Week Low
  • ₹653
  • 52 Week High
  • ₹1,022
  • Open Price₹724
  • Previous Close₹715
  • Volume838,957
  • 50 DMA₹804.50
  • 100 DMA₹825.40
  • 200 DMA₹828.20

Medplus Health Services Chart

Investment Returns

  • Over 1 Month -12.05%
  • Over 3 Month -19.95%
  • Over 6 Month -11.77%
  • Over 1 Year -24.56%

Smart Investing Starts Here Start SIP with Medplus Health Services for Steady Growth!

Invest Now

Medplus Health Services Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 40.2
  • PEG Ratio
  • 2.2
  • Market Cap Cr
  • 8,469
  • P/B Ratio
  • 4.3
  • Average True Range
  • 26.1
  • EPS
  • 17.5
  • Dividend Yield
  • 0
  • MACD Signal
  • -35.3
  • RSI
  • 29.51
  • MFI
  • 29.92

Latest Stock News Updates

Medplus Health Services Ltd - 543427 - Update Under Regulation 30 Read With Para A Part A Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Medplus Health Services Ltd - 543427 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 29, 2026 for Lone Furrow Investments Pvt Ltd

Medplus Health Services Ltd - 543427 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.

The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on July 29, 2026 for Agilemed Investments Pvt Ltd

Medplus Health Services Financials

Medplus Health Services Technicals

EMA & SMA

Current Price
₹704.95
-9.8 (-1.37%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹759.60
  • 50 Day
  • ₹804.50
  • 100 Day
  • ₹825.40
  • 200 Day
  • ₹828.20

Resistance and Support

709.32 Pivot Speed
  • R3 744.60
  • R2 734.30
  • R1 719.60
  • S1 694.60
  • S2 684.30
  • S3 669.60

Medplus Health Services Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-21 Quarterly Results
2026-05-20 Audited Results (Revised)
2026-01-30 Quarterly Results
2025-10-31 Quarterly Results
2025-08-02 Quarterly Results

Medplus Health Services Shareholding Pattern

40.19%
24.51%
15.45%
14.38%
5.44%

About Medplus Health Services

Medplus Health Services is engaged in the business of provision of diagnostic services, pathological services and laboratory testing services. View More
  • NSE Symbol
  • MEDPLUS
  • BSE Symbol
  • 543427
  • Chairman.,Executive Director,Managing Director,Chief Executive Officer
  • GANGADI MADHUKAR REDDY
  • ISIN
  • INE804L01022

Similar Stocks to Medplus Health Services

Medplus Health Services FAQs

Medplus Health Services share price is ₹704 As on 31 July, 2026 | 19:42

The Market Cap of Medplus Health Services is ₹8469.1 Cr As on 31 July, 2026 | 19:42

The P/E ratio of Medplus Health Services is 40.2 As on 31 July, 2026 | 19:42

The PB ratio of Medplus Health Services is 4.3 As on 31 July, 2026 | 19:42

The 52 week High & Low of Medplus Health Services is ₹1022.2/₹653 respectively As on 31 July, 2026 | 19:42

Open FREE Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23